stockportfolio.pro
STAAR Surgical Company P/E Ratio 2010–2025
STAAR Surgical Company (STAA) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -8.2%/yr over 15 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | — | — |
| FY 2023 | 72.58 | +19.6% |
| FY 2022 | 60.68 | -62.8% |
| FY 2021 | 163.04 | -80.9% |
| FY 2021 | 854.83 | +662.3% |
| FY 2020 | 112.13 | -61.3% |
| FY 2018 | 290.09 | — |
| FY 2017 | — | — |
| FY 2016 | — | — |
| FY 2016 | — | — |
| FY 2015 | — | — |
| FY 2014 | 1642.00 | — |
| FY 2012 | — | — |
| FY 2011 | 262.25 | — |
| FY 2010 | — | — |
| FY 2010 | — | — |
Source: STAAR Surgical Company SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for STAAR Surgical Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSTAAR Surgical Company — frequently asked questions
What is STAAR Surgical Company's price-to-earnings ratio?
STAAR Surgical Company (STAA) reported price-to-earnings ratio of 72.58 for fiscal year 2023, per its SEC filings.
How has STAAR Surgical Company's price-to-earnings ratio changed over time?
Between fiscal 2010 and 2025, STAA's price-to-earnings ratio declined at roughly 8.2% per year (compound annual rate), from 262.25 to 72.58.
Where does this data come from?
Figures are computed from STAAR Surgical Company's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.